The central role of fat tissue to FGF21 function was demonstrated in a lipoatrophic mouse model (mice severely depleted of adipose tissue) (47), where recombinant FGF21 treatment cannot correct the hyperglycemia and insulin resistance in these mice in contrast to wild-type animals. The gene discussed is FGF21; the disease is Insulin resistance.